Abstract
Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Current Psychopharmacology
Title:Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments
Volume: 5
Author(s): Maura Southwell and Scott McRobert
Affiliation:
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Abstract: Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Export Options
About this article
Cite this article as:
Southwell Maura and McRobert Scott, Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments, Current Psychopharmacology 2016; 5 (2) . https://dx.doi.org/10.2174/2211556005666160526111529
DOI https://dx.doi.org/10.2174/2211556005666160526111529 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues
Current Drug Metabolism Pharmacological Intervention at CCR1 and CCR5 as an Approach for Cancer: Help or Hindrance
Current Topics in Medicinal Chemistry Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer
Recent Patents on Anti-Cancer Drug Discovery Pharmacoinformatic Approaches to Design Natural Product Type Ligands of ABC-Transporters
Current Pharmaceutical Design Oral Hypoglycemics: A Review of Chemicals Used to Treat Type 2 Diabetes
Current Bioactive Compounds Proteasome Inhibitors in Cancer Therapy
Current Drug Targets MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design <sup>68</sup>Ga-labeled HBED-CC Variant of uPAR Targeting Peptide AE105 Compared with <sup>68</sup>Ga-NODAGA-AE105
Anti-Cancer Agents in Medicinal Chemistry Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Update to: The Aryl Hydrocarbon Receptor in Anticancer Drug Discovery: Friend or Foe?
Medicinal Chemistry Reviews - Online (Discontinued) Xanthomicrol: A Comprehensive Review of Its Chemistry, Distribution, Biosynthesis and Pharmacological Activity
Mini-Reviews in Medicinal Chemistry Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer
Current Medicinal Chemistry The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression
Current Drug Targets Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine Meet Our Editorial Board Member
The Natural Products Journal Patent Selections
Recent Patents on Biotechnology Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Developmental Expression of the Translocator Protein 18 kDa (TSPO) in Testicular Germ Cells
Current Molecular Medicine